1. 3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma. (December 2015) Authors: de la Puente, Pilar; Muz, Barbara; Gilson, Rebecca C.; Azab, Feda; Luderer, Micah; King, Justin; Achilefu, Samuel; Vij, Ravi; Azab, Abdel Kareem Journal: Biomaterials Issue: Volume 73(2015) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A CD138‐independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma. (5th January 2016) Authors: Muz, Barbara; de la Puente, Pilar; Azab, Feda; Luderer, Micah John; King, Justin; Vij, Ravi; Azab, Abdel Kareem Journal: British journal of haematology Issue: Volume 173:Number 1(2016) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia. Issue 1 (2nd January 2020) Authors: Muz, Barbara; Bandara, Nilantha; Mpoy, Cedric; Sun, Jennifer; Alhallak, Kinan; Azab, Feda; Rogers, Buck E.; Azab, Abdel Kareem Journal: Cancer biology & therapy Issue: Volume 21:Issue 1(2020) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib. (11th October 2015) Authors: Muz, Barbara; Azab, Feda; de la Puente, Pilar; Rollins, Scott; Alvarez, Richard; Kawar, Ziad; Azab, Abdel Kareem Other Names: Moreaux Jerome Academic Editor. Journal: BioMed research international Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma‐induced resistance. (9th January 2014) Authors: Azab, Feda; Vali, Shireen; Abraham, Joseph; Potter, Nicholas; Muz, Barbara; de la, Pilar; Fiala, Mark; Paasch, Jacob; Sultana, Zeba; Tyagi, Anuj; Abbasi, Taher; Vij, Ravi; Azab, Abdel Kareem Journal: British journal of haematology Issue: Volume 165:Number 1(2014:Apr.) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan‐class I PI3K inhibitor, buparlisib. Issue 11 (12th August 2014) Authors: Sahin, Ilyas; Azab, Feda; Mishima, Yuji; Moschetta, Michele; Tsang, Brian; Glavey, Siobhan V.; Manier, Salomon; Zhang, Yu; Sacco, Antonio; Roccaro, Aldo M.; Azab, Abdel Kareem; Ghobrial, Irene M. Journal: American journal of hematology Issue: Volume 89:Issue 11(2014:Nov.) Page Start: 1030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance. Issue 12 (2nd December 2017) Authors: Muz, Barbara; Kusdono, Hubert D.; Azab, Feda; de la Puente, Pilar; Federico, Cinzia; Fiala, Mark; Vij, Ravi; Salama, Noha N.; Azab, Abdel Kareem Journal: Leukemia & lymphoma Issue: Volume 58:Issue 12(2017) Page Start: 2916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma. Issue 7 (2nd July 2016) Authors: de la Puente, Pilar; Azab, Feda; Muz, Barbara; Luderer, Micah; Arbiser, Jack; Azab, Abdel Kareem Journal: Leukemia & lymphoma Issue: Volume 57:Issue 7(2016:Jul.) Page Start: 1677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗